Searched for
TORRENT PHARMA ACQUISITION
Torrent Pharma shares in focus after CCI clears Rs 19,500 crore acquisition of JB ChemicalsTorrent Pharmaceuticals shares are expected to see activity. The Competition Commission of India has approved Torrent Pharma's plan to acqu...23 Oct, 2025, 09.38 AM IST- CCI clears Torrent Pharma's proposal to buy stake in JB ChemicalsIndia's competition regulator CCI has approved Torrent Pharmaceuticals' acquisition of a stake in JB Chemicals and Pharmaceuticals. This de...21 Oct, 2025, 07.15 PM IST
- Torrent Pharma seeks CCI nod to acquire majority stake in JB Chemicals for Rs 19,500 croreTorrent Pharmaceuticals is looking to acquire J B Chemicals and Pharmaceuticals. The deal is worth Rs 19,500 crore. The company has sought ...18 Jul, 2025, 08.52 AM IST
- Torrent Pharma seeks CCI nod to acquire majority stake in JB Chemicals for Rs 19,500 crTorrent Pharmaceuticals is set to acquire a majority stake in J B Chemicals and Pharmaceuticals for Rs 19,500 crore, pending CCI approval. ...18 Jul, 2025, 08.49 AM IST
- Torrent Pharma to acquire additional 2.41% stake in JB Chemicals for Rs 620 croreTorrent Pharmaceuticals is set to acquire an additional 2.41% stake in J.B. Chemicals & Pharmaceuticals from a group of employees for Rs 62...03 Jul, 2025, 09.50 PM IST
- Torrent expects JB Chemicals acquisition deal to close in 15–18 monthsTorrent Pharmaceuticals is set to acquire a major stake in J B Chemicals. The deal is expected to finalize in 15 to 18 months. This acquisi...30 Jun, 2025, 02.49 PM IST
- JB Chemicals shares fall over 6% as Torrent makes open offer at 9% discountJB Chemicals & Pharmaceuticals shares declined after KKR announced the sale of its stake to Torrent Pharma, valuing JB Pharma at Rs 25,689 ...30 Jun, 2025, 09.55 AM IST
- Torrent Pharma says it has no disclosure to make now on potential Cipla stake buy deal reportsTorrent Pharma has stated that it does not have any information to disclose under listing regulations, in response to reports about the com...01 Sep, 2023, 11.48 AM IST
- Hot stocks: Brokerages maintain ‘overweight’ rating on DLF, Prestige Estates; KIMS, Torrent Pharma get ‘buy’The residential cycle has turned positive. Market fundamentals continue to be anchored around high affordability and market share continues...29 Sep, 2022, 12.29 PM IST
- Analysts cheer Torrent's Curatio buy, but Street's not so happySequoia-backed Curatio's top three brands - Tedibar, a baby soap, Atogla, a skin moisturiser for babies and Spoo, a baby shampoo - contribu...29 Sep, 2022, 06.42 AM IST
- Torrent Pharma appoints Aman Mehta as Director on its Board"At Torrent Power, Aman was involved at a challenging point in the business journey and was instrumental in bringing about a customer orien...29 Jul, 2022, 08.37 PM IST
- Torrent Pharma completes acquisition of Unichem Laboratories Ltdhe acquisition will accelerate Torrent's presence in the chronic space especially in the high growth segments of Indian Pharma market like ...14 Dec, 2017, 02.15 PM IST
- Torrent Pharma walks away with Unichem’s domestic business for Rs 3,600 croreThe deal will put Torrent among the country’s top five drugmakers. It will will also give Torrent access to 120 brands of Unichem in India ...08 Nov, 2017, 04.24 PM IST
- Torrent Pharma buys Glochem Unit in VizagET had reported in its May 27 edition that the two companies are in advanced talks for a possible transaction.01 Jul, 2016, 04.00 AM IST
- Torrent Pharma completes Zyg Pharma acquisitionDrug firm Torrent Pharmaceuticals today said that it has completed acquisition of Encore Group firm Zyg Pharma Pvt Ltd.18 Jul, 2015, 03.07 PM IST
- Torrent Pharmaceuticals rallies on acquisition plansTorrent Pharma rose nearly 3% in trade on the BSE on Wednesday, following reports that the drug firm has inked an agreement06 May, 2015, 09.58 AM IST
- Torrent Pharma to acquire Zyg Pharma for an undisclosed sumThe acquisition will help the company strengthen its position in niche dermatological segment, especially in developed markets like the US ...05 May, 2015, 10.44 PM IST
Load More
